The problem the paper addresses
Pulp regeneration depends on blood vessels, and the pro-angiogenic capacity of dental pulp stem cells declines with the age of the donor. Di and colleagues, publishing in the International Journal of Oral Science on 23 July 2026, identify a mechanism for that decline: impaired glycolytic metabolism driven by reduced expression of glucose transporter type 1 (GLUT1) and hexokinase 2 (HK2). The paper reports that inhibiting this pathway diminished endothelial tube formation, which is the causal half of the argument: aged cells underperform because their glucose metabolism is impaired, and restoring the metabolism should restore the function.
The intervention and the measured results
The intervention is a delivery system, an aminolyzed highly branched poly(β-amino ester), abbreviated HBPA, used to co-deliver GLUT1 and HK2 mRNA into mature DPSCs. The reported transfection efficiency exceeded 90% with what the authors describe as excellent biocompatibility. The measured outcomes come in two layers. In vitro, conditioned medium from the reprogrammed mature cells produced a 2.0-fold increase in capillary length and a 2.3-fold increase in branch points, restoring angiogenic potential to levels equivalent to immature DPSCs. In an in vivo tooth root slice model, tissue generated by the reprogrammed cells showed a vessel density of 10.2 vessels per square millimetre, 2.5-fold higher than untreated controls and, the authors report, statistically indistinguishable from the benchmark set by immature DPSCs.
Evidence level and what it means for the programme
This is in vitro work confirmed in an animal tissue model: T1 mechanism with T2 support on the ladder at /method/, with no human data. It bears on pulp-dentin-repair, the tier 3 programme where autologous cell grafts have already shown regenerated pulp tissue in patients (the Xuan et al. trial recorded in our /ledger/ on 22 August 2018). Donor age is a genuine translational barrier for autologous grafts, since the patients who most need pulp repair are rarely young. A credible rejuvenation step addresses that barrier. But a root slice model is not a root canal in a person, and the programme tier does not move on preclinical vascularization data, however clean the comparison against immature cells.
Where we differ from the coverage
A result like this is easily compressed into “rejuvenated stem cells regrow pulp”. What was restored is angiogenic signalling and vessel density in a model system, described by the authors as a translatable strategy for predictable, vascularized pulp regeneration. Predictable in a root slice is a hypothesis about the clinic, not a finding from it.
Provenance: every claim above traces to the paper’s published abstract, per our method at /method/.